ANI Pharmaceuticals Inc (ANIP)

63.05
2.21 3.39
NASDAQ : Health Care
Prev Close 65.26
Open 65.28
Day Low/High 62.10 / 65.74
52 Wk Low/High 26.80 / 73.54
Volume 146.46K
Avg Volume 120.00K
Exchange NASDAQ
Shares Outstanding 11.59M
Market Cap 756.45M
EPS 1.30
P/E Ratio 95.97
Div & Yield N.A. (N.A)

Latest News

5 Stocks Poised for Major Breakouts

5 Stocks Poised for Major Breakouts

These stocks are within range of triggering breakout trades. Here's how to trade them from here.

ANI Pharmaceuticals (ANIP) Shares Cross Below 200 DMA

ANI Pharmaceuticals (ANIP) Shares Cross Below 200 DMA

In trading on Thursday, shares of ANI Pharmaceuticals Inc crossed below their 200 day moving average of $51.16, changing hands as low as $47.25 per share. ANI Pharmaceuticals Inc shares are currently trading off about 23.4% on the day.

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Oversold Conditions For ANI Pharmaceuticals (ANIP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ANI Pharmaceuticals' Varied Offerings, Strategic Acquisitions Make It a Good Play for Investors

ANI Pharmaceuticals' Varied Offerings, Strategic Acquisitions Make It a Good Play for Investors

The Baudette, Minn.-based company has 79 products generating about $4 billion in sales and a number of other promising therapies in its pipeline.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANIP, AXU, BLDP, DVD, EGN, GPIC, IEC, IRS, OVBC, PIH, SAIA, VCO, WILC Downgrades: EFOI, LILAK, PCH, PEGA, PNM, PW, SUI, TOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

ANIP Crosses Above Average Analyst Target

ANIP Crosses Above Average Analyst Target

In recent trading, shares of ANI Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $66.00, changing hands for $66.39/share.

Strong On High Relative Volume: ANI Pharmaceuticals (ANIP)

Strong On High Relative Volume: ANI Pharmaceuticals (ANIP)

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a strong on high relative volume candidate

Commit To Purchase ANI Pharmaceuticals At $45, Earn 9.7% Annualized Using Options

Commit To Purchase ANI Pharmaceuticals At $45, Earn 9.7% Annualized Using Options

Investors eyeing a purchase of ANI Pharmaceuticals, Inc. stock, but cautious about paying the going market price of $59.32/share, might benefit from considering selling puts among the alternative strategies at their disposal.

These 5 Stocks Are Ready to Break Out

These 5 Stocks Are Ready to Break Out

Here's a technical look at how to trade five stocks poised for breakouts.

Commit To Purchase ANI Pharmaceuticals At $35, Earn 12.4% Annualized Using Options

Commit To Purchase ANI Pharmaceuticals At $35, Earn 12.4% Annualized Using Options

Investors considering a purchase of ANI Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $47.54/share, might benefit from considering selling puts among the alternative strategies at their disposal.

TheStreet Quant Rating: B- (Buy)